Accuray | ARAY - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Hologic USD 5.25B 197.2M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Surmodics USD 111.31M 7.59M 2025-06
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Trinity Biotech USD -54.72M 5.18M 2025-09